The MMS Experience

We are one team with one purpose – to positively improve lives worldwide.

At MMS, regardless of where our colleagues are located around the world, we are one team with one purpose – to positively improve lives worldwide. #OneMMS is more than just a hashtag. It’s a promise that our organization embraces the unique strengths and experiences of colleagues, providing everyone the opportunity to fortify and grow their talents, as well as enjoy dynamic career opportunities in life sciences.

DIVERSITY

Our global footprint provides MMS colleagues the opportunity to experience many different cultures and backgrounds, resulting in a work environment focused on inclusion and mutual respect. We celebrate and continuously welcome diversity to our team, and we keep diversity, equity, and inclusion (DEI) top of mind as we build global engagement activities, implement new processes, and innovative technology, open new positions, and offer new leadership opportunities.

TEAMWORK

We are committed to helping our colleagues achieve a common goal – making a positive impact on patients’ lives and the lives of their families. For each project we undertake, our team promotes flexible planning to assess subject matter expertise, process optimization, and risk planning for any project to ensure on-time delivery and added value to each client.

FLEXIBILITY & ADAPTABILITY

Our innovation-first, Kaizen culture allows us to embrace change, pioneer new processes and technologies, and work on continual improvement in every aspect of our business. Colleagues, at any level in our organization can propose improvements and see their suggestions come to fruition with our culture of continual, proven improvement.

OUR CLIENTS

Working at MMS gives our global colleagues a unique opportunity to work with a variety of industry-leading clients, therapeutic areas, drug development phases, and projects in the pharmaceutical, biotechnology, and medical device industries. Our extensive training, leadership, and mentor programs give colleagues from all backgrounds and experience levels the opportunity to learn.

Suggested For You

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval